Chad M. Robins - Mar 4, 2025 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Signature
/s/ Chad M Robins by Kyle Piskel, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Mar 4, 2025
Transactions value $
-$1,600,417
Form type
4
Date filed
3/6/2025, 07:17 PM
Previous filing
Feb 21, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +355K +13.78% $0.00 2.93M Mar 4, 2025 Direct
transaction ADPT Common Stock Sale -$567K -81.2K -2.77% $6.98 2.85M Mar 5, 2025 Direct F1
transaction ADPT Common Stock Sale -$253K -36.1K -1.27% $6.99 2.81M Mar 5, 2025 Direct F1
transaction ADPT Common Stock Award $0 +247K +8.78% $0.00 3.06M Mar 5, 2025 Direct F2
transaction ADPT Common Stock Sale -$781K -102K -3.34% $7.64 2.96M Mar 6, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The performance share units were granted on March 4, 2022, with respect to the three-year period ending on March 4, 2025. The issuer certified the achievement of the performance goals on March 5, 2025. The performance share units vested on March 5, 2025.
F3 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance share units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.